AACR24: Rebecca Porter, MD, Endometrial Cancer | Dana-Farber Cancer Institute [Video]

Endometrial Cancer research at AACR24: Dana-Farber’s Rebecca Porter, MD, PhD, says antibody-drug conjugate combined w/immunotherapy had impressive overall response rate in 16 pts with a rare subtype, but more research is needed.
Read more here: http://ms.spr.ly/6051cf5g7
Video published 4/10/2024